DUSA Pharmaceuticals Inc. (DUSA) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $56.65 -0.18%
Financial Fact:
Product revenues: 9.74M
Today's EPS Names:
GFL, NHTC, SKHY, More
Financial Fact:
Product revenues: 9.74M
Today's EPS Names:
GFL, NHTC, SKHY, More
Join SI Premium – FREE
DUSA Pharmaceuticals Inc. (NASDAQ: DUSA) reported Q1 EPS of $0.07, $0.06 better than the analyst estimate of $0.01. Revenue for the quarter came in at $11.1 million versus the consensus estimate of $9.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plexus Corp (PLXS) Tops Q4 EPS by 29c; offers guidance
- Towne Bank (TOWN) Tops Q3 EPS by 9c
- Merchants Bancorp (MBIN) Tops Q3 EPS by 67c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
